NCT05808712 Quality of Care in Relationship to Aborted Cancer Surgery
| NCT ID | NCT05808712 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Linkoeping University |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 350 participants |
| Start Date | 2023-03-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 350 participants in total. It began in 2023-03-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Surgery is often a central curative treatment for gastrointestinal tumors. Surgical treatment of diagnosed cancer tumors is decided after a comprehensive assessment of the patient's physical status, radiological assessments and after careful evaluation at the multidisciplinary conference. Despite the careful preoperative assessment of patients for curative surgery, the planned operation may unexpectedly need to be canceled. Of the patients who were planned for curative resection for pancreatic cancer in 2021 in Sweden, 90% received the intended surgery, and 10% of planned surgery was canceled. The reason for this was disseminated cancer or locally advanced disease in which radical resection is considered impossible to carry out. A systematic review of knowledge reveals a significant lack of evidence regarding patient-centered research and aborted cancer surgery. The studies in the project have different study designs and methods, and include focus group interviews with staff, translation and validation of a questionnaire to measure care needs, estimation of supportive care needs and patient experiences. An improved understanding and knowledge of patients' preferences and needs is needed to design interventions that can improve health-related quality of life. This project is dedicated to studying patients undergoing aborted cancer surgery, with the aim of improving the quality of care and meeting patients' care needs.
Eligibility Criteria
Inclusion Criteria: * \>18 years * cancer patients with different gastrointestinal cancer diagnosis Exclusion Criteria: \- not able to answer the questionnarie SCNS-SF34 in Swedish.
Contact & Investigator
Jenny Drott
PRINCIPAL INVESTIGATOR
Kirurgiska kliniken, Region Östergötland
Frequently Asked Questions
Who can join the NCT05808712 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05808712 currently recruiting?
Yes, NCT05808712 is actively recruiting participants. Contact the research team at Jenny.Drott@liu.se for enrollment information.
Where is the NCT05808712 trial being conducted?
This trial is being conducted at Linköping, Sweden, Linköping, Sweden.
Who is sponsoring the NCT05808712 clinical trial?
NCT05808712 is sponsored by Linkoeping University. The principal investigator is Jenny Drott at Kirurgiska kliniken, Region Östergötland. The trial plans to enroll 350 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.